The webinar aimed to discuss how DSI can contribute to the development of commercial products including the opportunities and risks that can arise from its use. The policy-science process under the CBD clearly showed that stakeholders are determined to keep the access to DSI in databanks open. However, open access does not necessarily mean that the access is for free. Future benefit-sharing models for the utilization of DSI are likely to be developed including terms and conditions at the level of access in data banks. While many stakeholders specifically focus on benefit-sharing options for the commercial use of DSI, a definition of the difference between non-commercial and commercial research is not available, as yet. Many commercial products are based on initially non-commercial research with the research results then being used for commercial research. This webinar aimed to inform about a 2-phase model of DSI generation and discussed the relevance of intellectual property (IP) to DSI and the role of patents. Examples of products which are already on the market or in the approval phase based on the utilization of DSI were presented. In the final part of the webinar the discussion was centred around the identification of individual benefit-sharing options in relation to the examples presented.